Related Experiment Video
Updated: Feb 14, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
MicroRNA-216b actively modulates diabetic angiopathy through inverse regulation on FZD5
Yuxiang Dai1, Hao Lu1, Shen Wang2
1Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Background:
In this work, we examined the angiogenic function of microRNA-216b in an in vitro rat diabetic model of myocardial microvascular endothelial cells (MMECs).
Methods:
MMECs were extracted from Wistar rats (MMEC(WI)) or diabetic Goto-Kakizaki (GK) rats (MMEC(GK)) and cultured in vitro. QRT-PCR was applied to compare miR-216b between MMEC(WI) and MMEC(GK). MiR-216b was downregulated in MMEC(GK). Its effects on angiogenic development, including invasion and proliferation, were evaluated. In MMEC(GK), putative miR-216b downstream target gene, frizzled class receptor 5 (FZD5), was evaluated by dual-luciferase reporter, qRT-PCR and western blot assays, respectively. FZD5 was further downregulated in MMEC(GK) with stable miR-216b downregulation to evaluate its functional role in regulating diabetic angiogenesis.
Results:
MiR-216b was markedly overexpressed in MMEC(GK). MiR-216b downregulation significantly enhanced angiogenesis in MMEC(GK) by promoting invasion and proliferation. FZD5 was inversely upregulated in miR-216b-downregulated MMEC(GK). Subsequently, FZD5 downregulation suppressed angiogenic development, by inhibiting invasion and proliferation in miR-216b-downregulated MMEC(GK).
Conclusion:
MicroRNA-216b was overexposed in diabetic MMECs and its downregulation may actively enhance angiogenesis in diabetic angiopathy through inverse regulation on FZD5.
Insights
MicroRNA-216b is overexpressed in diabetic heart cells, and reducing it boosts blood vessel growth. This suggests a new target for treating diabetic blood vessel disease by regulating FZD5.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Endothelial Cell Function
Background:
- Diabetic angiopathy involves abnormal blood vessel growth.
- MicroRNAs play a role in regulating cellular processes.
- Myocardial microvascular endothelial cells (MMECs) are crucial for heart blood supply.
Purpose of the Study:
- To investigate the role of microRNA-216b in diabetic angiogenesis.
- To explore the relationship between microRNA-216b and its target gene FZD5 in MMECs.
Main Methods:
- Cultured MMECs from Wistar and diabetic Goto-Kakizaki rats.
- Quantified microRNA-216b levels using qRT-PCR.
- Assessed angiogenic functions (invasion, proliferation).
- Validated FZD5 as a target using luciferase assays, qRT-PCR, and Western blot.
Main Results:
- MicroRNA-216b was overexpressed in diabetic MMECs.
- Downregulating microRNA-216b enhanced MMEC invasion and proliferation.
- FZD5 expression was inversely correlated with microRNA-216b levels.
- FZD5 downregulation inhibited angiogenesis in diabetic MMECs.
Conclusions:
- MicroRNA-216b is upregulated in diabetic MMECs.
- Downregulation of microRNA-216b promotes angiogenesis in diabetic conditions.
- This effect is mediated through the inverse regulation of FZD5.
Related Concept Videos
MicroRNAs
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
GPCRs Regulate Adenylyl Cylase Activity
Inverse Trigonometric Functions

